+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Maternal Health Market Size was valued at USD 20.5 Billion in 2022. The Maternal Health market industry is projected to grow from USD 23.8 Billion in 2023 to USD 72.6 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.80% during the forecast period (2023 - 2032). More parents are willing to meet with super-specialists and more people are seeking out maternal health care, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, Research Layer Database and Analyst Review
The key driver of the Maternal Health market's growth is the rise in demand for these services. Because parents tend to consult with super-specialists, the maternal health industry is expanding. One of the major priorities for community health programming is maternal health care. Maternal health services, according to the World Health Organisation, include "promoting, preventing, therapeutic, or rehabilitation facility or care for mother and child." Additionally, health issues are becoming more well-known. However, due to inadequate access to healthcare services and a lack of awareness, the majority of developing nations are unable to achieve the predicted reductions in child and maternal mortality. By boosting financial incentives for health care and collecting money for the proper utilisation of existing resources, nations like India, Bangladesh, Thailand, and Sri Lanka need to improve the quality of maternal and child care. The Janani Suraksha Yojana, Janani Express, 1098 service, facility-based newborn care service, and home-based newborn care service are only a few of the services that the Indian government provides in India.
In order to lower baby and maternal mortality as well as morbidity, maternal health services also monitor children's growth, nutrition, and mental health in addition to offering a healthy environment for both moms and children. By using optimal usage and enough care, it is also possible to prevent or control direct causes of maternal death, including as haemorrhage, obstructed labour, and decreased foetal and neonatal fatalities related with obstetric complications. As a result, there will be an increase in the demand for maternal health care, leading to market expansion.
All across the world, pregnant women use a variety of healthcare services. The out-of-pocket expenses for maternity care change based on a number of variables, such as the care model employed, insurance coverage, and the choice made by women to acquire medical treatments outside the normal parameters of maternity care. According to the WHO Global Health Expenditure Database, India's Out-of-Pocket Expenditure (OOPE) is higher than many other growing nations in Asia and Africa with slower economic growth and smaller economies. The WHO estimates that OOPE expenses cover over 86% of India's healthcare costs, which encourages the market's growth.
One of the main reasons for a bullish market forecast is the healthcare sector's rapid growth. Parents frequently follow maternal health procedures in order to consult with super-specialist physicians and protect the health of both the mother and the kid. Due to the difficulty of giving birth without the support of medical professionals who have the necessary expertise, as well as the lack of or limited access to prenatal care, pregnant moms frequently employ maternal health services, which is causing the market to expand. The availability of various nutritional and micronutrient supplementation options, such as those for iron, zinc, calcium, and early prenatal meals, is another factor influencing market expansion. These supplements help the mother and infant avoid illnesses and infections in addition to giving them the necessary amounts of key nutrients. In line with this, market growth is being positively impacted by the usability of digital claim processing and healthcare policy management systems. The market is expected to expand due to a variety of additional variables, including the rise in the proportion of women with the immunodeficiency virus and other chronic illnesses, the execution of numerous government efforts to enhance public health, and a number of other factors. Thus, driving the Maternal Health market revenue.
The global Maternal Health market segmentation, based on Type of Pregnancy, includes Intrauterine, Ectopic, Tubal, and Others. Intrauterine segment dominated the global market in 2022. The growing global preference for and understanding of maternal health accounts for this.
The global Maternal Health market segmentation, based on Complication, includes Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others. Miscarriage segment dominated the global market in 2022. This is due to the growth of miscarriages around the world, which has led to a greater need for maternal health care.
The global Maternal Health market segmentation, based on Care, includes Prenatal Care and Postnatal Care. Prenatal Care segment dominated the global Maternal Health market in 2022. The attention provided in this kind of care can help to explain this. For instance, care involves both the early detection and treatment of health issues as well as the prevention of those issues.
The global Maternal Health market segmentation, based on Drug Class, includes Hormones, Nutritives, Analgesics, Anti-Infectives, and Others. Nutritives segment dominated the global Maternal Health market in 2022. This is explained by the growing understanding of the significance of diet both before and after pregnancy.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, Research Layer Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific Maternal Health market dominated this market in 2022 (45.80%). The lack of facilities providing super-specialty care, parents' increased willingness to consult super-specialists, the expansion of the area's developed healthcare infrastructure, and ongoing research projects for the creation of cutting-edge technologies and services are some of the causes of this. Moreover, China’s Maternal Health market held the largest market share and the Indian Maternal Health market was the fastest growing market in the Asia-Pacific region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, Research Layer Database and Analyst Review
The North America Maternal Health Market is expected to register significant growth from 2023 to 2032. Due to its large population, growing awareness of maternity services and fertility treatments, increasing in vitro fertilisation (IVF) popularity in the United States, rising infertility rates, technological advancements, and delayed pregnancy trends, North America offers lucrative opportunities for players in the mother and child healthcare market. It is also projected that an increase in the tendency of women delaying delivery will boost market expansion. Further, the U.S. Maternal Health market held the largest market share, and the Canada Maternal Health market was the fastest growing market in the North America region.
Europe Maternal Health market accounted for the healthy market share in 2022. National professional employees are stationed in the WHO country offices to help with health system reform, and WHO/Europe has ongoing partnership agreements on this specific subject with a number of nations. Market titans from around the world have also invested heavily in the region. Further, the German Maternal Health market held the largest market share, and the U.K Maternal Health market was the fastest growing market in the European region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Maternal Health market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Maternal Health industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Maternal Health industry to benefit clients and increase the market sector. In recent years, the Maternal Health industry has offered some of the most significant advantages to medicine. Major players in the Maternal Health market, including Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson, are attempting to increase market demand by investing in research and development Type of Pregnancys.
Cleveland Clinic is a publisher of medical publications. The company's publications address a wide range of topics, such as rheumatoid arthritis, heart attacks, women's health, ageing, cancer, diabetes, infertility, and health literacy. These publications try to dispel widespread myths about drugs, healthcare, and medical procedures. In July 2022, Cleveland Clinic received a USD 14.2 million grant for atrial fibrillation research from the National Institutes of Health. Four synergistic efforts financed over a five-year period will improve and pioneer patient care for atrial fibrillation, the most common heart rhythm issue.
Several medications and vaccines are developed, produced, marketed, and discovered by Sanofi, a healthcare company. It also provides multiple sclerosis, cancer, and other medicines, as well as human immunisations for defence against a variety of bacterial and viral infections. Additionally, the business offers goods for women's health, digestion, allergy, cough, cold, flu, and sinus infections, as well as painkillers, vitamins, minerals, and supplements. Sanofi's research and development efforts are mostly focused on creating combination therapies to increase treatment efficacy and novel biologic formulations to produce precision medicines. It operates in the Americas, Asia-Pacific, Africa, and the Middle East. Sanofi's headquarters are in Paris, Ile-de-France, in France.
· Agile Therapeutics
· Sanofi
· Okamoto Industries
· Fuji Latex Co
· Reckitt Benckiser Group
· Johnson and Johnson
June 2022: According to studies from the Cleveland Clinic, those with obesity who underwent weight-loss surgery had a 32% lower risk of acquiring cancer and a 48% lower risk of dying from it. The study was released in JAMA.
· Intrauterine
· Ectopic
· Tubal
· Others
· Miscarriage
· Premature Labor & Birth
· Preeclampsia
· Gestational Diabetes
· Placenta Previa
· Others
· Prenatal Care
· Postnatal Care
· Hormones
· Nutritives
· Analgesics
· Anti-Infectives
· Others
· North America
- U.S.
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 20.5 Billion |
|
Market Size 2023 |
USD 23.8 Billion |
|
Market Size 2032 |
USD 72.6 Billion |
|
Compound Annual Growth Rate (CAGR) |
14.80% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Type of Pregnancy, Complication, Care, Drug Class, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson |
|
Key Market Opportunities |
Growing customer awareness regarding benefits of maternal health |
|
Key Market Dynamics |
Increase in adoption of mother and child healthcare services and willingness among parents to seek opinion from super-specialists |
The global Maternal Health market was valued at USD 20.5 billion in 2022, and it is estimated to reach USD 72.6 billion by 2032.
The global market is projected to grow at a CAGR of 14.80% during the forecast period, 2023-2032.
Asia Pacific had the largest share in the global market
The key players in the market are Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson
The Intrauterine Type of Pregnancy dominated the market in 2022.
The Miscarriage Complication had the largest share in the global market.
Report Code :
RL6546
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst